22nd Global Congress on Biotechnology (CSE)

22nd Global Congress on Biotechnology (CSE)
Map Unavailable

Date/Time
Date(s) - 28/02/2019 - 02/03/2019
8:00 am - 5:00 pm

Categories


 About Conference:

The International “22nd Global Congress on Biotechnology” brings a chance to gift and discuss all the innovations in Biotechnology. This conference permits leading educational scientists, researchers and industrialists from everywhere the planet to exchange and share their experiences, recent innovations, sensible challenges, advanced instrumentation and analysis results. Biotechnology has a broader set of speakers, and a broader array of programs geared toward each scientists and industrialists. This meeting offers a powerful likelihood to speak regarding the foremost recent advancements latest developments among the sector.

Conference Series LLC Ltd is happy to welcome you to our “Biotechnology 2019” that is to be held on February 28-March 2, 2019 at Berlin, Germany. This includes prompt keynote speakers and displays, Oral and Poster displays, and far a lot of. This additionally includes varied workshops guided by eminent delegates.

Why to attend?

Biotechnology 2019 may be a world stage for exhibiting analysis regarding designation, hindrance and management and exchanging concepts regarding it and through this fashion, adds to the unfold of data in Biotechnology and child health for the advantage of every learned community and business. The organizing committee of the “Biotechnology 2019”is preparing for associate energizing and instructive meeting program furthermore as comprehensive lectures, symposia, workshops on an expansion of topics, poster displays and various programs for participants from all over the world. We tend to tend to ask you to the Biotechnology 2019, where you will confirm to possess a major experience with students from all around the world. All members of the commercial Biotechnology 2019, organizing committee expect to fulfil you in Berlin, Germany.

Targeted audience:

Students
Research Scholars
Scientists
Young Researchers
Biotechnology Industries
Biotech Food Industry
Agro industry
Digital medicine and therapeutic companies
Pharma, biotech, and tech companies
Health care industries
Venture capital, private equity, and institutional investors
Buy and sell-side analysts
Biotechnology researchers
Business associates
Biotechnology entrepreneurs
Training institutes
Industrial Biotechnology associations

Sessions and Tracks

Track 1:  Biotechnology

Industrial biotechnology is that the applying of biotechnology for industrial functions, along with industrial fermentation. The exploitation of cells like micro-organisms, or components of cells like enzymes, to urge industrially useful product in sectors like chemicals, food and feed, detergents, paper and pulp, textiles and biofuels. Industrial Biotechnology offers a premier forum bridging basic analysis and R&D with later-stage development for property bio primarily based industrial and environmental applications. An increasing vary of chemicals and materials, like base chemicals, polymers, industrial catalysts, enzymes and detergents area unit created exploitation biotechnology. In 2010, the sales of business chemicals created victimization biotechnology in a very minimum of 1 step of the assembly technique equaled €92bn globally, and this could be expected to increase to €228bn by 2015

Track 2: Pharmaceutical Biotechnology

Pharmaceutical Biotechnology is that the science that covers all technologies needed for manufacturing, producing and registration of biological medicine. It contributes in style and delivery of recent therapeutic medicine, diagnostic agents for medical tests, and in sequence medical aid for correcting the medical symptoms of hereditary diseases. The Pharmaceutical Biotechnology is wide unfolding, starting from several moral problems to changes in tending practices and a major contribution to the event of economic system.
Biopharmaceuticals consists of enormous biological molecules that area unit protein. They aim the underlying mechanisms and pathways of a sickness or ailment; it’s a comparatively young trade.  The global market for drugs and related contract manufacturing organization (CMO) services was $15.9 billion in 2012. The composite revenues projected for 2013 are nearly $17.6 billion and $28.7 billion in 2018, a compound annual growth rate (CAGR) of 10.4% between 2013 and 2018.

Track 3: Algal Biotechnology

Algal biotechnology may be a technology developed using algae .  Biotechnology is to more the understanding of the ecology of microalgae. This can assist with the event of commercial-scale small protoctist culturing techniques for the assembly of bioactive compounds, cultivation feed, fine chemicals, and renewable fuels. in addition, environmental applications like CO2 bioremediation, management of excessive protoctist growth and development of management ways for installation managers square measure investigated. Trangenesis in protoctist may be a advanced and invasive technology. Selectable marker genes, promoters, communicator genes, transformation techniques, and different genetic tools and ways square measure already accessible for numerous species and presently ~25 species square measure accessible to genetic transformation. Fortuitously, large-scale sequencing comes also are planned, ongoing, or completed for many of those species. A $2.4M purchase order for Algae.Tec algae production technology as a follow-up to an initial investment of A$1.5M by Reliance, with additional investments of AU$1.2 million over the next 2 years.

Track 4 : Medical Biotechnology

Medical biotechnology refers to a meditative or diagnostic product or a vaccinum that consists of or has been created in living organisms and will be factory-made via recombinant. Medical Biotechnology features tremendous impact on meeting the requirements of patients and their families because it not solely compasses medicines and medical specialty that are factory-made employing a biotechnological method, however conjointly sequence and cell therapies and tissue designed product. Today, the bulk of innovative medicines, whether or not factory-made victimization biotechnology or via a chemical synthesis sort of aancient tiny molecule medication, also as several diagnostic product, ar created accessible by applying fashionable biotechnology in their development and producing. Investment in medical and health research and development (R&D) in the U.S. grew by 13.3% from 2013 to 2015. Industry invested more than any other sector, representing 64.7% of total spending in 2015, followed by the federal government at 22.6%.

Track 5: Plant and Agriculture Biotechnology

Biotechnology has been practiced for an extended time, as folks have wanted to enhance agriculturally necessary organisms selectively and breeding. An example of ancient agricultural biotechnology is that the development of sickness-resistant wheat varieties by cross-breeding completely different wheat sorts till the specified disease resistance was gift in an exceedingly ensuing new selection. Gene-splicing may end up in improved keeping properties to create transport of recent manufacture easier, giving shoppers access to nutritionally valuable whole foods and preventing decay, damage, and loss of nutrients.  Biotechnology is outlined as a group of tools that uses living organisms (or elements of organisms) to create or modify a product, improve plants, trees or animals, or develop microorganisms for specific uses. This treatise can focus solely on agricultural crop biotechnology. Biotechnology encompasses variety of tools and parts of typical breeding techniques, plant physiology etc.  The global botanical and plant-derived drug market was valued at $21.4 billion in 2011 and should reach $22.1 billion in 2012. Total market value is expected to reach $26.6 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 3.7%.

Track 6: Environmental Biotechnology

Biotechnology is applied and wont to study the natural atmosphere. Environmental biotechnology might additionally imply that one try and harness process for industrial uses and exploitation. Environmental biotechnology as “the development, use and regulation of biological systems for correction of contaminated environments and for environment-friendly processes (green producing technologies and property development)”. Environmental biotechnology will merely be represented as “the best use of nature, within the style of plants, animals, bacteria, fungi and protoctist, to supply renewable energy, food and nutrients in an exceedingly synergistic integrated cycle of profit creating methods wherever the waste of every process becomes the feedstock for one more process”. U.S. sales of environmental biotechnology products was valued at $241.2 million in 2012. This is expected to increase at a total compound annual growth rate (CAGR) of 7.9%, with 2013 sales of $261.9 million, rising to $382.3 million in 2018.

Track 7: Nano Biotechnology

Nano biotechnology refers to the intersection of engineering science and biology. Only if the topic is one that has solely emerged terribly recently, Bio engineering science and Nano biotechnology function blanket terms for numerous connected technologies. The foremost necessary objectives that square measure often found in Nano biology involve applying Nano tools to relevant medical/biological issues and refinement these applications. The imaging of native biomolecules, biological membranes, and tissues is additionally a significant topic for the Nano-biology researchers. Alternative topics regarding Nano biology embrace the utilization of cantilever array sensors and therefore the application of Nano-photonics for manipulating molecular processes in living cells. The global nanomedical market was valued at $134.4 billion in 2016. This market is projected to grow at a compound annual growth rate (CAGR) of 14.0% from 2017-2022, and should reach $293.1 billion by 2022 from $151.9 billion in 2017.

Track 8: Biotechnology and Bioprocess Engineering

Bioprocess Engineering combines biotechnology and engineering for the producing of materials from renewable feedstock.  This field includes basic bio molecular analysis on proteins, enzymes and microbes, in addition as work on biosensors, bio separations and bioreactors.  Applications embrace food process and preservation; pharmaceutical, nutraceutical and sweetener production; air and waste material treatment; bio-based structural motifs for above molecular architectures; microfluidics for bioreactors and DNA chips; bioenergy; and applications within the pulp and paper business.  There square measure natural links to medicine applications, like drug metabolism, tissue engineering and bio-based therapeutic treatments. The alternative U.S chemical end-use product market is expected to increase from $149.9 billion in 2016 to an estimated $345.6 billion by 2021. It should reach $884.1 billion by 2026, with a compound annual growth rate (CAGR) of 19.4% for the period of 2016-2026.

Track 9: Systems and Synthetic Biotechnology

Systems and synthetic Biotechnology could be a comparatively new field in medical specialty analysis. It focuses on engineering new or changed communication proteins to form desired communication pathways within the cell. Thanks to very good regulation, many cells, like photoreceptors and different neurons in vertebrates, will live for many years. Thanks to elucidation of the intricacies of cellular restrictive mechanisms we are able to currently play evolution on our time scale: re-design proteins and communication pathways to attain our ends. Systems and synthetic Biology could be a novel field that finds its origin at the intersection of biology and engineering. It’s a multidisciplinary effort created by scientists to grasp the functioning of biological organisms, cells & genes and implementation of artificial genetic processes to convey specific characteristics to an organism. It will even be wont to develop a totally new biological system. The global market for synthetic and natural waxes will grow from $1.3 billion in 2017 to $1.9 billion by 2022, at a compound annual growth rate (CAGR) of 8.5% from 2017 to 2022.

Track 10: Biotechnology Applications

Biotechnology has application in four major industrial areas, as well as health care (medical), crop production and agriculture, nonfood (industrial) uses of crops and alternative product (e.g. perishable plastics, edible fat, biofuels), and environmental uses. Applied biology and Biotechnology focusses on organism or eukaryotic cells, relevant enzymes and proteins, applied biological science and molecular biotechnology, genetic science and genetic science, applied microbes and cell physiology, environmental biotechnology, method and product and a lot of.

Approximately one hundred twenty corporations are known to be concerned in animal biotechnology and square measure profiled within the report. This square measure a mixture of animal tending corporations and biotechnology corporations. The global market for synthetic biology will grow from nearly $4.4 billion in 2017 to $13.9 billion by 2022, with a compound annual growth rate (CAGR) of 26.0% for the period of 2017-2022.

Track 11: CRISPR Based Technologies and Bio-products

Genome piece of writing and also the utilization of CRISPR based technologies are expected to revolutionize the assembly of succeeding generation of bio product. DCB12 will concentrate on the foremost recent developments among the employment of CRISPR/Cas9 and different CRISPR based technologies in relevance the event and production of biopharmaceuticals, biochemical, agricultural crops and travel applications. The global market for genetic modification therapies should grow from $2.3 billion in 2018 to reach $17.4 billion by 2023, growing at a compound annual growth rate (CAGR) of 49.9% during the forecast period of 2018-2023.

Track 12: Biomass and Bioenergy

Bioenergy is that the energy contained in organic matter (biomass) which may be born-again into energy forms that we will use directly, like electricity, heat and liquid fuel. Biomass is any organic matter of recently living plant or animal origin. Not like coal, the organic matter isn’t fossilized. Historically woody biomass has been used for bioenergy; but more modern technologies have enlarged the potential resources to those like agricultural residues, oilseeds and protects. These advanced bioenergy technologies give the property development of the bioenergy trade, while not competitor with the standard agricultural trade for land and resources. Bioenergy plants can range from small domestic heating systems to multi-megawatt industrial plants requiring hundreds of thousands of tons of biomass fuel each year. A variety of technologies exists to unharness and use the energy contained in biomass. They vary from combustion technologies that square measure well verified and wide used round the world for generating electricity generation, to rising technologies that convert biomass into liquid fuels for road, ocean and transportation. The global market for bioproducts should reach $714.6 billion by 2021 from $466.6 billion in 2016 at a compound annual growth rate (CAGR) of 8.9%, from 2016 to 2021.

Track 13: Bio economy

The bio economy refers to the property production and conversion of biomass for a variety of food, health, fiber, and alternative industrial product yet as energy. The bio economy encompasses all industries and sectors manufacturing, managing or otherwise creating use of biological resources (including organic waste), like agriculture, forestry, and fisheries. The fashionable bio economy is predicated on data and innovation in biosciences, at the side of alternative technologies like engineering, chemistry, computing and nanotechnologies. The bio economy as an important component of the Strategy’s three main priorities of:

•           Smart growth: developing an information and innovation based mostly economy,

•           Sustainable growth: promoting a lot of resource economical, greener and a lot of competitive economy;

•           Inclusive growth: fostering a high employment economy delivering social and territorial cohesion.

The global bio economy will grow from nearly 108.0 million tons in 2015 to 121.6 million tons by 2020 with a compound annual growth rate (CAGR) of 2.4% for the period of 2015-2020.

Track 14: Biotechnology Enterprise and Entrepreneurship

A thriving biotechnology enterprise depends on trained professionals UN agency perceives science and UN agency are practiced within the complexities of biotechnology commercialization. This exciting new program brings along a powerful science foundation with biotechnology enterprise and entrepreneurship, providing distinctive a singular novel instructional venue for scientists to higher perceive the whole biotechnology enterprise and problems unique to the trade. The global market for ubiquitin proteasome research and development was estimated at nearly $2.9 billion in 2013. The market should total more than $5.5 billion by 2018, and have a five-year compound annual growth rate (CAGR) of 14.2% from 2013 to 2018.

Track 15: Biotechnology Products

Biotechnology refers to the manipulation of organisms, living system or parts of the living organisms to make products, environment or system for the benefit of human beings. The product that may be made by biotechnology process may include; pharmaceuticals, foods and water purification. However, it has various definitions since it involves mixture of disciplines, such as physiology, genetics, medicine and bioprocess engineering, thus, simple definition of biotechnology is manipulation of organism scientifically at a molecular level in order to come up with productive products for human use. U.S. sales of environmental biotechnology products was valued at $241.2 million in 2012. This is expected to increase at a total compound annual growth rate (CAGR) of 7.9%, with 2013 sales of $261.9 million, rising to $382.3 million in 2018.

Track 16: Biotechnology Companies & Market Analysis

Biotechnology plays a very important role in company standards, services, and developing new merchandise. Biotechnology involves the spectrum of life science-based analysis firms performing on transformative technologies for a good vary of industries.

While agriculture, material science and ecology square measure major areas of analysis, the biggest impact is created within the field drugs. As an outsized player within the analysis and development of prescription drugs, the role of biotechnology within the care field is plain. From genetic analysis and manipulation to the formation of recent medicine, several biotech companies square measure reworking into pharmaceutical and biopharmaceutical leaders. This research category includes various comprehensive reports on research methods, biotech companies, tools, technologies, and equipment commonly used in the biotech industry. You will also find business reports covering funding, product pipelines, mergers and acquisitions, and strategies for development. The “green” and “white” biotech sectors are also covered in the reports herein. The global market for research antibodies should reach $3.0 billion by 2022 from $2.4 billion in 2017 at a compound annual growth rate (CAGR) of 4.8%, from 2017 to 2022.

Track 17: Europe Biotech Market

The European biotech sector had a jolting past. Today, but it have reached a record momentum and flourishing like ne’er before. Stock exchanges, like Euronext, support Biotech corporations and have contributed for the most part to the record high we tend to see these days.

The global monetary crisis hit Europe in 2008. Like a tsunami, it torus through the biotech sector, giving up the detritus of shattered corporations and leading to widespread cost-cutting with workers being ordered off and analysis shelved. Nearly a decade later, the European biotech sector is flourishing once more and has reached a momentum that was quite unpredictable within the aftermath of 2008. The global market for microbiology technology, equipment and consumables market reached $9.8 billion revenue in 2015. The market should reach nearly $12.3 billion by 2020, increasing at a compound annual growth rate (CAGR) of 4.6% from 2015 to 2020.

Track 18: Biotechnology Capital & Grants

Every new business wants some start-up capital, for analysis, development and production, permits and licensing and alternative overhead prices, additionally to what’s required to pay your workers, if you’ve got any. Biotechnology merchandise arises from eminent biotech corporations. These corporations area unit engineered by gifted people in possession of a scientific breakthrough that’s translated into a product or service plan that is ultimately brought into development. Entrepreneurs begin biotechnology corporations for varied reasons, however making revolutionary merchandise and tools that impact the lives of probably a lot of folk’s area unit one among the basic reasons why all entrepreneurs begin biotechnology corporations. In 2010, the sales of business chemicals created victimization biotechnology in a very minimum of 1 step of the assembly technique equalled €92bn globally, and this could be expected to increase to €228bn by 2015

Track 19: Stem Cell Biotechnology

Stem cell biotechnology may be a revolutionary sub field of biotechnology to develop and improve tools and generate a lot of on through modify and regenerative drugs. Vegetative cell technology is very important role in tissue regeneration drugs the premise for cell transplantation is that blood cells (red cells, white cells and platelets) and immune cells (lymphocytes) arise from the stem cells, that square measure gift in marrow, peripheral blood and cord blood. Intense medical aid or medical aid kills the patient’s stem cells. This stops the stem cells from making enough blood and immune cells. Only 12.0% of federal stem cell research funding was estimated to be allocated to human embryonic stem cell research in 2016 ($172 million out of $1.436 billion).

Track 20: Animal biotechnology

Animal biotechnology is a immense field of study and includes the subsequent topics: use of animals in analysis clones transgenic animals and gene pharming animal health. Animals play a significant role in primary analysis. The utilization of animal models permits a lot of fast assessment of the consequences of recent medical treatments and alternative merchandise. Testing on live animal models needs that 2 or a lot of species be used as a result of completely different effects square measure discovered in several animals. If issues are detected within the animal tests, human subjects are never recruited for trials. The animals used most frequently square measure pure-bred mice and rats, however alternative species are used. Another extraordinarily valuable analysis animal is that the zebra fish, a hardy fish tank fish. Dogs are used for the study of cancer, heart disease and lung disorders. HIV and AIDS analysis is conducted on monkeys and chimpanzees. The contribution of this sector in national economy was approximately 3.9% in 2011-12. India ranks first in the world in milk production with an estimated production of 132.4 million tonnes in 2012-13. India is also third largest egg-producer in the world, over 69.7 billion eggs were produced in 2012-13.

Track 21: Microbial/Industrial biotechnology

Industrial or white biotechnology uses enzymes and micro-organisms to create bio primarily based merchandise in sectors like chemicals, food and feed, detergents, paper and pulp, textiles and bioenergy. The appliance of commercial biotechnology has been well-tried to create important contributions towards mitigating the impacts of global climate change in these and alternative sectors. Additionally to environmental advantages, biotechnology will improve industry’s performance and products worth and, because the technology develops and matures, white biotechnology can yield additional and additional viable solutions for our surroundings. These innovative solutions bring additional advantages for each our climate and our economy. The global industrial enzymes market should reach $7.0 billion by 2023 from $5.5 billion in 2018 at a compound annual growth rate (CAGR) of 4.9% for the period 2018-2023.

Track 22: Food biotechnology

Food biotechnology is getting used to enhance nutrition, enhance food safety and quality, and defend food crops and animals from diseases that might otherwise threaten our stable, affordable, and wholesome food offer. Biotechnology incorporates a role to play in guaranteeing that safe and easy food is made on existing farm land to fulfill the increasing wants of the world’s growing population. The global market for equipment used in food processing and packaging is expected to reach nearly $31.5 billion by 2020 from about $25.7 billion in 2015, rising at a compound annual growth rate (CAGR) of 4.2%, from 2015 to 2020.

Track 23: Marine Biotechnology

Marine biotechnology, typically stated as “blue biotechnology”, exploits the variety found in marine environments in terms of the shape, structure, physiology and chemistry of marine organisms, several of that haven’t any equivalent toward land, in which change new materials to be realized. Marine biotechnology could be an information generation and conversion process: it unlocks access to biological compounds and provides novel uses for them.  By exploring and harnessing marine materials, entirely new uses in square measures aloof from the marine are doubtless to be found. Marine biotechnology is a chance recognized by policy manufacturers and therefore the enterprise sector as giving vital potential to fill market gaps for brand new product. The global market for flexible-foam reached $29.1 billion in 2017. The market should reach $36.9 billion by 2022 at a compound annual growth rate (CAGR) of 4.9% for the period of 2017-2022.

Track 24:Genetic Engineering

Genetic engineering, also called genetic modification or genetic manipulation, is the direct manipulation of an organism’s genes using biotechnology. It is a set of technologiesused to change the genetic makeup of cells, including the transfer of genes within and across species boundaries to produce improved or novel organisms. New DNA is obtained by either  isolating and copying the genetic material of interest using recombinant DNA methods or by artificially synthesising the DNA. A construct is usually created and used to insert this DNA into the host organism. The global market for genetic modification therapies should grow from $2.3 billion in 2018 to reach $17.4 billion by 2023, growing at a compound annual growth rate (CAGR) of 49.9% during the forecast period of 2018-2023.

Track 25:Cell/Molecular Biotechnology

Cell and Molecular biotechnology is that the use of laboratory techniques to check and modify nucleic acids and proteins for applications in areas like human and animal health, agriculture, and therefore the atmosphere. Molecular biotechnology results from the convergence of the many areas of analysis, like biology, biology, organic chemistry, immunology, genetics, and cell biology. It’s associate degree exciting field fueled by the power to transfer genetic info between organisms with the goal of understanding vital biological processes or making a helpful product. The tools of molecular biotechnology are often applied to develop and improve medication, vaccines, therapies, and diagnostic tests that may improve human and animal health. Molecular biotechnology has applications in plant and animal agriculture, cultivation, chemical and textile producing, forestry, and food process. The global digital molecular biotechnology market totaled $425.0 million in 2017 and is estimated to reach $746.0 million by 2022, growing at a compound annual growth rate (CAGR) of 11.9% for the period of 2017-2022.

AGENDA

SCIENTIFIC PROGRAM
Thursday, 28th February DAY 1

08:30-09:00 Registrations
09:00-09:30 Introduction
09:30-09:50 COFFEE BREAK
09:50-11:50
Meeting Hall 01 KEYNOTE LECTURES
MEETING HALL 01 MEETING HALL 02
11:50-13:10 Talks On:
Biotechnology
Talks On:
Pharmaceutical Biotechnology
Policies and Incentives for Industrial Biotech Pharmaceutical Process and Quality Control
Process Improvement for Biobased Materials Biologics and Biosimilars
Biorefineries: Building the Bioeconomy Biomarker Discovery and Gene Therapy
Livestock Industry Recombinant vaccines and Monoclonal
Antibodies
13:10-13:15 GROUP PHOTO
13:15-14:00 LUNCH BREAK
MEETING HALL 01 MEETING HALL 02
14:00-16:00 Talks On: Algal Biotechnology Talks On: Medical Biotechnology
Large Scale Algal Bioprocesses Tissue engineering & regenerative medicine
Extraction and Conversion of Microalgal
Lipids Pharmacogenomics
Applications of Algae in Food and Feed Biomedical Innovations
Algae Based Technology to Treat Industrial
Effluents Monoclonal Antibodies
Bio-Remediation Using Algae Viral Vector Manufacturing for Gene
Therapies
Algal Farming for Biofuels and Other Valuable
Products Protein Interaction
16:00-16:20 COFFEE BREAK
MEETING HALL 01 (16:20-17:00) MEETING HALL 01 (17:00-18:00)
Young Researchers in Biotechnology Workshop

SCIENTIFIC PROGRAM
Friday, 01 March DAY 2

09:00-10:30
Meeting Hall 01 KEYNOTE LECTURES
10:30-10:50 COFFEE BREAK
MEETING HALL 01 MEETING HALL 02
10:50-12:50 Talks On:
Plant and Agriculture Biotechnology
Talks On:
Environmental Biotechnology
Plant tissue culture Biotechnology for treatment of industrial
effluents
Tissue culture media Biotechnology for toxic site reclamation
Genetic engineering of plants &
Applications of transgenic plants
Biotechnology in restoration of degraded
lands
Transgenic plants as bioreactors Bioremediation & Biodegradation
Applications of Plant
Biotechnology in Crop Improvement Environmental Pollution
Application of Biotechnology in Agriculture Biodegradation and Bioremediation
Plant Tissue Culture Techniques &
GM crops
Molecular Farming and Applications
12:50-13:35 LUNCH BREAK
MEETING HALL 01 MEETING HALL 02
13:35-15:55 Talks On:
Nano Biotechnology
Talks On:
Biotechnology and Bioprocess Engineering
Advances in nano biotechnology Biomolecular Engineering
Nano-biosensors Biocatalysis & Biotransformation
Nanocarrier-formulations Biosynthesis and Metabolic Engineering
Protein-based Nanostructures Bioseparation and Biopurification Engineering
DNA-based Nanostructures Bioprocess Control and System Engineering
Bioconjucated Silica Particles Biosensor and Bioelectronics
Bioeconomy Challenges for EU Regions Cell Culture Engineering & Tissue Bioprinting
15:55-16:15 COFFEE BREAK
MEETING HALL 01 (16:15-17:00) MEETING HALL 01 (17:00-18:00)
Poster Presentations Workshop

SCIENTIFIC PROGRAM
Saturday, 2nd March DAY 3

09:00-10:30
Meeting Hall 01 KEYNOTE LECTURES
10:30-10:50 COFFEE BREAK
MEETING HALL 01 MEETING HALL 02
10:50-12:50 Talks On:
Stem Cell Biotechnology Talks On: Industrial biotechnology
Stem Cell Niche Bioprocess/Fermentation Technology
Cancer & Adult Stem Cell Downstream processing
Stem Cell Therapy Enzyme Technology
Stem Cell Transplantation Biotransformation
Induced Pluripotent Cells Biomass and Bioenergy
Embryonic Stem Cells Microbial mining and Metal biotechnology
12:50-13:35 LUNCH BREAK
MEETING HALL 01 MEETING HALL 02
13:35-15:55 Talks On: Food biotechnology Talks On: Animal biotechnology
Food Processing and Preservation Animal cell culture
Food Quality Standards Cell viability and cytotoxicity
Food Microbiology Cell transformation and cloning
Food Additives Organ and tissue engineering
Food Packaging Transgenic animals
Dairy technology
Fermentation
15:55-16:15 COFFEE BREAK
MEETING HALL 01 (16:15-17:00) MEETING HALL 01 (17:00-18:00)
Young Researchers in Biotechnology Workshop
Awards & Closing Ceremony

Please contact the event manager Marilyn (marilyn.b.turner(at)nyeventslist.com ) below for:
– Multiple participant discounts
– Price quotations or visa invitation letters
– Payment by alternate channels (PayPal, check, Western Union, wire transfers etc)
– Event sponsorship

NO REFUNDS ALLOWED ON REGISTRATIONS
Prices may go up any time. Service fees included in pricing.

Rate This Event:
1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)
Loading...

More Events

No Events